MAVIRET
Google image searchProduct monograph
Active ingredients
glecaprevir, 50 MG/SACHET
pibrentasvir, 20 MG/SACHET
DIN: 02522470
Dosage form(s): GRANULES
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 22-APR-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AP — Antivirals for treatment of HCV infections (ATC, ATC/DDD)
- J05AP57 — GLECAPREVIR AND PIBRENTASVIR (ATC/DDD)
Reference brand drug: Maviret
